{
"NDC": {
"NDCCode": "62847-002-01",
"PackageDescription": "1 VIAL, SINGLE-USE in 1 CONTAINER (62847-002-01) > 17 mL in 1 VIAL, SINGLE-USE",
"NDC11Code": "62847-0002-01",
"ProductNDC": "62847-002",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Vibativ",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Telavancin Hydrochloride",
"DosageFormName": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"RouteName": "INTRAVENOUS",
"StartMarketingDate": "20091105",
"EndMarketingDate": null,
"MarketingCategoryName": "NDA",
"ApplicationNumber": "NDA022110",
"LabelerName": "Theravance Biopharma R&D, Inc.",
"SubstanceName": "TELAVANCIN HYDROCHLORIDE",
"StrengthNumber": "15",
"StrengthUnit": "mg/mL",
"Pharm_Classes": "Lipoglycopeptide Antibacterial [EPC],Lipoglycopeptides [Chemical/Ingredient]",
"DEASchedule": null,
"Status": "Deprecated",
"LastUpdate": "2018-11-22",
"PackageNdcExcludeFlag": null,
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20181231",
"StartMarketingDatePackage": null,
"EndMarketingDatePackage": null,
"SamplePackage": null
}
}